Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
1301 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Ukraine 47
1302 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 64
1303 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 67
1304 Apheresis Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2025 Standard Therapy USA 65
1305 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 58
1306 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Germany 57
1307 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy RUSSIAN FEDERATION 22
1308 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 33
1309 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Slovakia 41
1310 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Greece 54
1311 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Ukraine 46
1312 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Argentina 26
1313 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 70
1314 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 59
1315 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 34
1316 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Norway 53
1317 Apheresis Allogeneic Other Immune System Hematology 2025 Standard Therapy USA 19
1318 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 6
1319 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 68
1320 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 72
1321 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 64
1322 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy United Kingdom 33
1323 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Italy 63
1324 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 33
1325 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 61
1326 Apheresis Allogeneic Acute lymphocytic leukemia Hematology 2025 Standard Therapy Germany 51
1327 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 64
1328 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 54
1329 Apheresis Autologous Testicular tumor Hematology 2025 Standard Therapy Germany 42
1330 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 52
1331 Apheresis Autologous T-cell lymphoma Hematology 2025 Standard Therapy Germany 49
1332 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 73
1333 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 62
1334 Apheresis Autologous Lymphoma Hodgkin Hematology 2025 Standard Therapy Portugal 39
1335 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 60
1336 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 70
1337 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 64
1338 Apheresis Autologous T-Cell Lymphoma Hematology 2025 Standard Therapy Germany 60
1339 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 62
1340 Apheresis Autologous Mantle Cell Lymphoma Hematology 2025 Standard Therapy Germany 60
1341 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 43
1342 Apheresis Allogeneic Myeofibrosis Hematology 2025 Standard Therapy Poland 37
1343 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russia 22
1344 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy NETHERLANDS 66
1345 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 57
1346 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 56
1347 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 78
1348 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 65
1349 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 53
1350 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Portugal 41
1351 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 56
1352 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 22
1353 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 36
1354 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 65
1355 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
1356 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Sweden 73
1357 Apheresis Allogeneic NK LGL Leukemia Hematology 2025 Standard Therapy USA 42
1358 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 29
1359 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 71
1360 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
1361 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Czechia 64
1362 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 10
1363 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Brazil 57
1364 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 21
1365 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Lithuania 54
1366 Apheresis Allogeneic Richter Transformation From CLL Hematology 2025 Standard Therapy Poland 55
1367 Apheresis Allogeneic Richter Transformation From CLL Hematology 2025 Standard Therapy Poland 63
1368 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
1369 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 55
1370 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 26
1371 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy NETHERLANDS 63
1372 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 33
1373 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy KAZAKHSTAN 10
1374 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Italy 53
1375 Apheresis Allogeneic Hodking Lymphoma Hematology 2025 Standard Therapy Belgium 62
1376 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 54
1377 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 66
1378 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Spain 47
1379 Apheresis Allogeneic T-Cell Lymphoma Hematology 2025 Standard Therapy Poland 25
1380 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Portugal 62
1381 Apheresis Autologous No Data Hematology 2025 Standard Therapy Portugal 65
1382 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 38
1383 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 60
1384 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 65
1385 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2025 Standard Therapy Germany 61
1386 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 41
1387 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 73
1388 Apheresis Autologous T-Cell Lymphoma Hematology 2025 Standard Therapy Germany 49
1389 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 61
1390 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy United Kingdom 2
1391 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 20
1392 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 5
1393 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2025 Standard Therapy USA 2
1394 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Slovakia 56
1395 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
1396 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 60
1397 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 64
1398 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 42
1399 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 63
1400 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 59